# VMA21

## Relevance tier by entity

|Entity|Tier|Description            |
|:------:|:----:|-----------------------|
|FL    |1   |high-confidence FL gene|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source       |frequency (%)|
|:------:|:-------------:|:-------------:|
|FL    |GAMBL genomes|5.08         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   | 0.000          |  0.000         |
|DLBCL |No  |No                   | 3.430          | 81.281         |
|FL    |No  |Yes                  |25.632          |598.612         |


> [!NOTE]
> First described in FL in 2021 by [HÃ¼bschmann D](https://pubmed.ncbi.nlm.nih.gov/33953289)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/VMA21_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/VMA21_protein_hg38.html)

![image](images/proteinpaint/VMA21_NM_001017980.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/VMA21.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/VMA21_hg38.html)

![image](images/proteinpaint/VMA21.svg)
## VMA21 Expression
![image](images/gene_expression/VMA21_by_pathology.svg)
<!-- ORIGIN: hubschmannMutationalMechanismsShaping2021b -->
